Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
Hendrianus The, Interventional & Structural Cardiology Fellow at Heart and Brain Hospital, Chung-Ang University Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I would like to share our recently published meta-analysis evaluating intravenous cangrelor in hemodynamically unstable patients undergoing PCI.
We found that IV cangrelor was associated with reduced mortality, with the most pronounced benefit observed in patients with cardiogenic shock, along with improved coronary flow.
These findings support its role as a valuable alternative when oral P2Y12 inhibitor administration is not feasible, pending confirmation in large-scale randomized trials.”
Title: Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Authors: Hendrianus Hendrianus, Young-Hoon Jeong, Sang Yeub Lee, Jun Hwan Cho, Jinhwan Jo, Diana A. Gorog, Jacek Kubica, Udaya S. Tantry, Paul A. Gurbel, Sang-Wook Kim
Read the Full Article on Critical Care
Stay updated with Hemostasis Today.
-
Feb 17, 2026, 15:42Paul Wischmeyer: Nutrient Absorption in the GI Tract
-
Feb 17, 2026, 15:40Mahesan Subramaniam: Reversing Age-Related Decline in Blood Stem Cells
-
Feb 17, 2026, 15:38Wolfgang Miesbach: How a Single Mutation Can Flip Immunity into VITT
-
Feb 17, 2026, 15:34Jeff June: When Safety Warnings Outlive the Evidence – What Statins Teach Us About Stroke Prevention and Biology
-
Feb 17, 2026, 15:32Gabrielle Sarlon: Key Messages to Improve VTE Management in Women of Childbearing Age
-
Feb 17, 2026, 15:27Piezo1 Gain-of-Function Mutation Explains Thromboembolic Complications in Hereditary Xerocytosis – JTH
-
Feb 17, 2026, 15:20Giulia Simini: MATRON Study Selected as Top-Scoring Abstract at the BSH Annual Scientific Meeting
-
Feb 17, 2026, 15:082026 NLA Clinical Consensus: Updated LDL and ApoB Targets in Familial Hypercholesterolemia
-
Feb 17, 2026, 14:56Mohamed Sikkander Abdul Razak: Three Days in Nature and Long-Lasting Immune Benefits